Works matching DE "RILUZOLE"
Results: 263
Validation of qMT and CEST MRI as Biomarkers of Response to Treatment After Lumbar Spinal Cord Injury in Rats.
- Published in:
- NMR in Biomedicine, 2025, v. 38, n. 4, p. 1, doi. 10.1002/nbm.70015
- By:
- Publication type:
- Article
Motor neuron disease presenting with acute hypercapnic respiratory failure.
- Published in:
- African Journal of Thoracic & Critcal Care Medicine, 2023, v. 29, n. 1, p. 27, doi. 10.7196/AJTCCM.2023.v29i1.573
- By:
- Publication type:
- Article
IMPACTO DO TRATAMENTO COM RILUZOL NA EFICIÊNCIA E REGRESSÃO DA ESCLEROSE LATERAL AMIOTRÓFICA.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 11, p. 1, doi. 10.54751/revistafoco.v16n11-127
- By:
- Publication type:
- Article
12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive-Compulsive Disorder.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 6, p. 1453, doi. 10.1038/npp.2013.343
- By:
- Publication type:
- Article
Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
- Published in:
- Neuroepidemiology, 2019, v. 53, n. 1/2, p. 73, doi. 10.1159/000499485
- By:
- Publication type:
- Article
Mineralization of Riluzole by Heterogeneous Fenton Oxidation Using Natural Iron Catalysts.
- Published in:
- Catalysts (2073-4344), 2023, v. 13, n. 1, p. 68, doi. 10.3390/catal13010068
- By:
- Publication type:
- Article
Assessing the Effect of Riluzole on Motor Unit Discharge Properties.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 11, p. 1053, doi. 10.3390/brainsci14111053
- By:
- Publication type:
- Article
Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 8, p. 1040, doi. 10.3390/brainsci12081040
- By:
- Publication type:
- Article
The Dying Forward Hypothesis of ALS: Tracing Its History.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 3, p. 300, doi. 10.3390/brainsci11030300
- By:
- Publication type:
- Article
Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma.
- Published in:
- Current Eye Research, 2016, v. 41, n. 1, p. 59, doi. 10.3109/02713683.2015.1004719
- By:
- Publication type:
- Article
Pantoprazole and riluzole target H<sup>+</sup>/K<sup>+</sup>‐ATPases and pH‐sensitive K<sup>+</sup> channels in pancreatic cancer cells.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 9, p. 1641, doi. 10.1002/ijc.35076
- By:
- Publication type:
- Article
Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis.
- Published in:
- Frontiers in Neurology, 2016, p. 1, doi. 10.3389/fneur.2016.00100
- By:
- Publication type:
- Article
QUANTIFICATION OF HAZARDOUS HIGH BOILING SOLVENTS IMPURITIES IN ANTI-DIABETIC DRUG LINAGLIPTIN BY NOVEL GC-ALS METHOD DEVELOPMENT AND VALIDATION.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 3, p. 1089, doi. 10.31788/RJC.2023.1638331
- By:
- Publication type:
- Article
The profile of amyotrophic lateral sclerosis in natives of Western Himalayas: Hospital-based cohort study.
- Published in:
- Journal of Neurosciences in Rural Practice, 2018, v. 9, n. 3, p. 305, doi. 10.4103/jnrp.jnrp_8_18
- By:
- Publication type:
- Article
Antitumor Activity and Mechanism Study of Riluzole and Its Derivatives.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2020, v. 19, n. 3, p. 217, doi. 10.22037/ijpr.2020.1101149
- By:
- Publication type:
- Article
Analysis of riluzole's profile of use in a Central Hospital in Lisbon.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 2357, doi. 10.2147/PPA.S167861
- By:
- Publication type:
- Article
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 4, p. 534, doi. 10.1111/pcmr.12694
- By:
- Publication type:
- Article
Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells.
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 1, p. 105, doi. 10.1111/pcmr.12327
- By:
- Publication type:
- Article
Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.
- Published in:
- Pigment Cell & Melanoma Research, 2014, v. 27, n. 2, p. 263, doi. 10.1111/pcmr.12207
- By:
- Publication type:
- Article
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study.
- Published in:
- Psychiatry & Clinical Neurosciences, 2016, v. 70, n. 8, p. 332, doi. 10.1111/pcn.12394
- By:
- Publication type:
- Article
Riluzole But Not Melatonin Ameliorates Acute Motor Neuron Degeneration and Moderately Inhibits SOD1-Mediated Excitotoxicity Induced Disrupted Mitochondrial Ca<sup>2+</sup> Signaling in Amyotrophic Lateral Sclerosis.
- Published in:
- Frontiers in Cellular Neuroscience, 2017, v. 10, p. 1, doi. 10.3389/fncel.2016.00295
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2019
- Publication type:
- Correction Notice
Estimation of Riluzole Levels in Human Milk and Infant Exposure During Its Use in a Patient With ALS.
- Published in:
- Journal of Human Lactation, 2018, v. 34, n. 2, p. 355, doi. 10.1177/0890334417737042
- By:
- Publication type:
- Article
c-Jun N-Terminal Kinase Promotes Stress Granule Assembly and Neurodegeneration in C9orf72-Mediated ALS and FTD.
- Published in:
- Journal of Neuroscience, 2023, v. 43, n. 17, p. 3186, doi. 10.1523/JNEUROSCI.1799-22.2023
- By:
- Publication type:
- Article
Loss of Activity-Induced Mitochondrial ATP Production Underlies the Synaptic Defects in a Drosophila Model of ALS.
- Published in:
- Journal of Neuroscience, 2022, v. 42, n. 42, p. 8019, doi. 10.1523/JNEUROSCI.2456-21.2022
- By:
- Publication type:
- Article
Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 11111, doi. 10.3390/ijms252011111
- By:
- Publication type:
- Article
Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1871, doi. 10.3390/ijms25031871
- By:
- Publication type:
- Article
Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1751, doi. 10.3390/ijms25031751
- By:
- Publication type:
- Article
Edaravone: A Novel Possible Drug for Cancer Treatment?
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1633, doi. 10.3390/ijms25031633
- By:
- Publication type:
- Article
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15340, doi. 10.3390/ijms242015340
- By:
- Publication type:
- Article
Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4820, doi. 10.3390/ijms22094820
- By:
- Publication type:
- Article
Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 344, doi. 10.3390/ijms21010344
- By:
- Publication type:
- Article
Spinal Glutamate Transporters Are Involved in the Development of Electroacupuncture Tolerance.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 3, p. 357, doi. 10.3390/ijms17030357
- By:
- Publication type:
- Article
Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03293-3
- By:
- Publication type:
- Article
Proteomic profiling of the brain from the wobbler mouse model of amyotrophic lateral sclerosis reveals elevated levels of the astrogliosis marker glial fibrillary acidic protein.
- Published in:
- European Journal of Translational Myology, 2023, v. 33, n. 3, p. 1, doi. 10.4081/ejtm.2023.11555
- By:
- Publication type:
- Article
Expanding the availability of medications for amyotrophic lateral sclerosis in Australia.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Effectiveness of Riluzole as a pharmacotherapeutic treatment option for early cervical myelopathy: a double-blinded, placebo-controlled randomised controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Features of the Effects of Glutamatergic System Modulators in the Model of Hyperthermal Seizures in Rat Pups.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2022, v. 174, n. 1, p. 43, doi. 10.1007/s10517-022-05645-6
- By:
- Publication type:
- Article
SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 4, p. 946, doi. 10.1002/acn3.52013
- By:
- Publication type:
- Article
Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 11, p. 1985, doi. 10.1002/acn3.51885
- By:
- Publication type:
- Article
Improved stratification of ALS clinical trials using predicted survival.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 4, p. 474, doi. 10.1002/acn3.550
- By:
- Publication type:
- Article
Inhibiting drug efflux transporters improves efficacy of ALS therapeutics.
- Published in:
- Annals of Clinical & Translational Neurology, 2014, v. 1, n. 12, p. 996, doi. 10.1002/acn3.141
- By:
- Publication type:
- Article
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2014, v. 1, n. 5, p. 340, doi. 10.1002/acn3.60
- By:
- Publication type:
- Article
Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients.
- Published in:
- Translational Neurodegeneration, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40035-020-00203-4
- By:
- Publication type:
- Article
T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1202834
- By:
- Publication type:
- Article
Low T-cell reactivity to TDP-43 peptides in ALS.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1193507
- By:
- Publication type:
- Article
A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome.
- Published in:
- Asian Pacific Journal of Tropical Biomedicine, 2014, v. 4, p. S335, doi. 10.12980/APJTB.4.2014C205
- By:
- Publication type:
- Article
Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Pharmacologic Management Strategies in ALS #301.
- Published in:
- Journal of Palliative Medicine, 2016, v. 19, n. 3, p. 335, doi. 10.1089/jpm.2015.0362
- By:
- Publication type:
- Article
Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease.
- Published in:
- Toxins, 2020, v. 12, n. 10, p. 666, doi. 10.3390/toxins12100666
- By:
- Publication type:
- Article